関連レポート

抗炎症薬の世界市場：2031年予測

出版元：Transparency Market Research  出版元について

発行年：2024年2月

定価：Single User License $5795 Multi User License $8795 Corporate User License $11795

ご請求は円換算（お見積り日TTSレート）となります。

ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。

納品形態：PDF by Email

当調査レポートは英文 232ページになります。

商品コード：TMR231

当レポートは発行年月に関わらず、受注の都度、最新情報にアップデートしてお届けいたします。ご希望情報の追加等もご相談可能です。

レポート紹介

局所抗菌薬の世界市場規模は2022年で65億ドル、2031年に100億ドル、市場の平均年成長率は5.1%にて増加する見込みです。

当レポートでは、局所抗菌薬の市場予測-2031年、各種セグメント別市場分析(薬剤クラス別、剤形別、国地域別、等)、市場ダイナミクス、パイプライン分析、主要企業プロフィールなどの情報を盛り込み、概略以下の構成でお届けいたします。

【レポート構成概要】
■局所抗菌薬の世界市場予測2017-2031年
・市場規模(US$)

■薬剤クラス別、市場-2031年
・テトラサイクリン
・アミノグリコシド
・エリスロマイシン
・クリンダマイシン
・その他
※(市場規模US$)　

■剤形別、市場-2031年
・軟膏
・クリーム
・粉末
・ジェル
・その他
※(市場規模US$)

■適応症別、市場-2031年
・皮膚感染症
・眼感染症
・臭汗症
・その他
※(市場規模US$)　

■製品タイプ別、市場-2031年
・処方箋
・一般用医薬品（OTC）
※(市場規模US$)

■流通チャネル別、市場-2031年
・病院薬局
・小売薬局
・その他
※(市場規模US$)

■主要国地域別市場-2031年
北米
・米国、カナダ
欧州
・ドイツ、英国、フランス
・イタリア、スペイン
・その他欧州
アジア太平洋
・日本、中国、インド
・ASEAN、韓国
・オーストラリア/ニュージーランド
・その他アジア太平洋
中南米
・ブラジル、メキシコ
・その他中南米
中東アフリカ
・GCC諸国、南アフリカ
・その他中東アフリカ
※地域別に各種セグメント別の細分化データ掲載、詳細は目次参照

■市場分析
市場ダイナミクス
パイプライン分析
主要製品/ブランド分析
主要な合併、買収

■局所抗菌薬の主要企業プロフィール動向
Novartis AG
GlaxoSmithKline Plc
Perrigo Company Plc
Pfizer, Inc.
Almirall, S.A.
Bausch Health Companies, Inc. (Valeant Pharmaceuticals International, Inc.)
Medimetriks Pharmaceuticals, Inc.
Taro Pharmaceutical Industries Ltd.
Mayne Pharma Group Limited

（全232頁）

Table of Contents (英文詳細目次）

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Topical Antibiotics Market

4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Topical Antibiotics Market Analysis and Forecast, 2017–2031

5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry

6. Global Topical Antibiotics Market Analysis and Forecast, by Drug Class
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Drug Class, 2017–2031
6.3.1. Tetracycline
6.3.2. Amino-glycosides
6.3.3. Erythromycin
6.3.4. Clindamycin
6.3.5. Others
6.4. Market Attractiveness, by Drug Class

7. Global Topical Antibiotics Market Analysis and Forecast, by Dosage Form
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Dosage Form, 2017–2031
7.3.1. Ointments
7.3.2. Creams
7.3.3. Powders
7.3.4. Gels
7.3.5. Others
7.3.6. 7.4 Market Attractiveness, by Dosage Form

8. Global Topical Antibiotics Market Analysis and Forecast, By Indication
8.1. Introduction and Definitions
8.2. Key Findings/Developments
8.3. Market Value Forecast, By Indication, 2017–2031
8.3.1. Skin Infection
8.3.2. Eye Infection
8.3.3. Bromhidrosis
8.3.4. Others
8.4. Market Attractiveness, By Indication

9. Global Topical Antibiotics Market Analysis and Forecast, by Product Type
9.1. Introduction and Definitions
9.2. Key Findings/Developments
9.3. Market Value Forecast, by Product Type, 2017–2031
9.3.1. Prescription
9.3.2. OTC
9.4. Market Attractiveness, by Product Type

10. Global Topical Antibiotics Market Analysis and Forecast, by Distribution Channel
10.1. Introduction and Definitions
10.2. Key Findings/Developments
10.3. Market Value Forecast, by Distribution Channel, 2017–2031
10.3.1. Hospital Pharmacies
10.3.2. Retail Pharmacies
10.3.3. Others
10.4. Market Attractiveness, by Distribution Channel

11. Global Topical Antibiotics Market Analysis and Forecast, by Region
11.1. Key Findings
11.2. Market Value Forecast, by Region, 2017–2031
11.2.1. North America
11.2.2. Europe
11.2.3. Asia Pacific
11.2.4. Latin America
11.2.5. Middle East & Africa
11.3. Market Attractiveness, by Region

12. North America Topical Antibiotics Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Drug Class, 2017–2031
12.2.1. Tetracycline
12.2.2. Amino-glycosides
12.2.3. Erythromycin
12.2.4. Clindamycin
12.2.5. Others
12.3. Market Attractiveness, by Drug Class
12.4. Market Value Forecast, by Dosage Form, 2017–2031
12.4.1. Ointments
12.4.2. Creams
12.4.3. Powders
12.4.4. Gels
12.4.5. Others
12.5. Market Attractiveness, by Dosage Form
12.6. Market Value Forecast, By Indication, 2017–2031
12.6.1. Skin Infection
12.6.2. Eye Infection
12.6.3. Bromhidrosis
12.6.4. Others
12.7. Market Attractiveness, By Indication
12.8. Market Value Forecast, by Product Type, 2017–2031
12.8.1. Prescription
12.8.2. OTC
12.9. Market Attractiveness, by Product Type
12.10. Market Value Forecast, by Distribution Channel, 2017–2031
12.10.1. Hospital Pharmacies
12.10.2. Retail Pharmacies
12.10.3. Others
12.11. Market Attractiveness, by Distribution Channel
12.12. Market Value Forecast, by Country/Sub-region, 2017–2031
12.12.1. U.S.
12.12.2. Canada
12.13. Market Attractiveness Analysis
12.13.1. By Drug Class
12.13.2. By Dosage Form
12.13.3. By Indication
12.13.4. By Product Type
12.13.5. By Distribution Channel
12.13.6. By Country

13. Europe Topical Antibiotics Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Drug Class, 2017–2031
13.2.1. Tetracycline
13.2.2. Amino-glycosides
13.2.3. Erythromycin
13.2.4. Clindamycin
13.2.5. Others
13.3. Market Attractiveness, by Drug Class
13.4. Market Value Forecast, by Dosage Form, 2017–2031
13.4.1. Ointments
13.4.2. Creams
13.4.3. Powders
13.4.4. Gels
13.4.5. Others
13.5. Market Attractiveness, by Dosage Form
13.6. Market Value Forecast, By Indication, 2017–2031
13.6.1. Skin Infection
13.6.2. Eye Infection
13.6.3. Bromhidrosis
13.6.4. Others
13.7. Market Attractiveness, By Indication
13.8. Market Value Forecast, by Product Type, 2017–2031
13.8.1. Prescription
13.8.2. OTC
13.9. Market Attractiveness, by Product Type
13.10. Market Value Forecast, by Distribution Channel, 2017–2031
13.10.1. Hospital Pharmacies
13.10.2. Retail Pharmacies
13.10.3. Others
13.11. Market Attractiveness, by Distribution Channel
13.12. Market Value Forecast, by Country/Sub-region, 2017–2031
13.12.1. Germany
13.12.2. U.K.
13.12.3. France
13.12.4. Italy
13.12.5. Spain
13.12.6. Rest of Europe
13.13. Market Attractiveness Analysis
13.13.1. By Drug Class
13.13.2. By Dosage Form
13.13.3. By Indication
13.13.4. By Product Type
13.13.5. By Distribution Channel
13.13.6. By Country/Sub-region

14. Asia Pacific Topical Antibiotics Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Drug Class, 2017–2031
14.2.1. Tetracycline
14.2.2. Amino-glycosides
14.2.3. Erythromycin
14.2.4. Clindamycin
14.2.5. Others
14.3. Market Attractiveness, by Drug Class
14.4. Market Value Forecast, by Dosage Form, 2017–2031
14.4.1. Ointments
14.4.2. Creams
14.4.3. Powders
14.4.4. Gels
14.4.5. Others
14.5. Market Attractiveness, by Dosage Form
14.6. Market Value Forecast, By Indication, 2017–2031
14.6.1. Skin Infection
14.6.2. Eye Infection
14.6.3. Bromhidrosis
14.6.4. Others
14.7. Market Attractiveness, By Indication
14.8. Market Value Forecast, by Product Type, 2017–2031
14.8.1. Prescription
14.8.2. OTC
14.9. Market Attractiveness, by Product Type
14.10. Market Value Forecast, by Distribution Channel, 2017–2031
14.10.1. Hospital Pharmacies
14.10.2. Retail Pharmacies
14.10.3. Others
14.11. Market Attractiveness, by Distribution Channel
14.12. Market Value Forecast, by Country/Sub-region, 2017–2031
14.12.1. China
14.12.2. Japan
14.12.3. India
14.12.4. Australia & New Zealand
14.12.5. Rest of Asia Pacific
14.13. Market Attractiveness Analysis
14.13.1. By Drug Class
14.13.2. By Dosage Form
14.13.3. By Indication
14.13.4. By Product Type
14.13.5. By Distribution Channel
14.13.6. By Country/Sub-region

15. Latin America Topical Antibiotics Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Drug Class, 2017–2031
15.2.1. Tetracycline
15.2.2. Amino-glycosides
15.2.3. Erythromycin
15.2.4. Clindamycin
15.2.5. Others
15.3. Market Attractiveness, by Drug Class
15.4. Market Value Forecast, by Dosage Form, 2017–2031
15.4.1. Ointments
15.4.2. Creams
15.4.3. Powders
15.4.4. Gels
15.4.5. Others
15.5. Market Attractiveness, by Dosage Form
15.6. Market Value Forecast, By Indication, 2017–2031
15.6.1. Skin Infection
15.6.2. Eye Infection
15.6.3. Bromhidrosis
15.6.4. Others
15.7. Market Attractiveness, By Indication
15.8. Market Value Forecast, by Product Type, 2017–2031
15.8.1. Prescription
15.8.2. OTC
15.9. Market Attractiveness, by Product Type
15.10. Market Value Forecast, by Distribution Channel, 2017–2031
15.10.1. Hospital Pharmacies
15.10.2. Retail Pharmacies
15.10.3. Others
15.11. Market Attractiveness, by Distribution Channel
15.12. Market Value Forecast, by Country/Sub-region, 2017–2031
15.12.1. Brazil
15.12.2. Mexico
15.12.3. Rest of Latin America
15.13. Market Attractiveness Analysis
15.13.1. By Drug Class
15.13.2. By Dosage Form
15.13.3. By Indication
15.13.4. By Product Type
15.13.5. By Distribution Channel
15.13.6. By Country/Sub-region

16. Middle East & Africa Topical Antibiotics Market Analysis and Forecast
16.1. Introduction
16.1.1. Key Findings
16.2. Market Value Forecast, by Drug Class, 2017–2031
16.2.1. Tetracycline
16.2.2. Amino-glycosides
16.2.3. Erythromycin
16.2.4. Clindamycin
16.2.5. Others
16.3. Market Attractiveness, by Drug Class
16.4. Market Value Forecast, by Dosage Form, 2017–2031
16.4.1. Ointments
16.4.2. Creams
16.4.3. Powders
16.4.4. Gels
16.4.5. Others
16.5. Market Attractiveness, by Dosage Form
16.6. Market Value Forecast, By Indication, 2017–2031
16.6.1. Skin Infection
16.6.2. Eye Infection
16.6.3. Bromhidrosis
16.6.4. Others
16.7. Market Attractiveness, By Indication
16.8. Market Value Forecast, by Product Type, 2017–2031
16.8.1. Prescription
16.8.2. OTC
16.9. Market Attractiveness, by Product Type
16.10. Market Value Forecast, by Distribution Channel, 2017–2031
16.10.1. Hospital Pharmacies
16.10.2. Retail Pharmacies
16.10.3. Others
16.11. Market Attractiveness, by Distribution Channel
16.12. Market Value Forecast, by Country/Sub-region, 2017–2031
16.12.1. GCC Countries
16.12.2. South Africa
16.12.3. Rest of Middle East & Africa
16.13. Market Attractiveness Analysis
16.13.1. By Drug Class
16.13.2. By Dosage Form
16.13.3. By Indication
16.13.4. By Product Type
16.13.5. By Distribution Channel
16.13.6. By Country/Sub-region

17. Competition Landscape
17.1. Market Player – Competition Matrix (By Tier and Size of Companies)
17.2. Market Share Analysis, by Company (2022)
17.3. Company Profiles
17.3.1. Novartis AG
17.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.1.2. Product Portfolio
17.3.1.3. Financial Overview
17.3.1.4. SWOT Analysis
17.3.1.5. Strategic Overview
17.3.2. GlaxoSmithKline plc
17.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.2.2. Product Portfolio
17.3.2.3. Financial Overview
17.3.2.4. SWOT Analysis
17.3.2.5. Strategic Overview
17.3.3. Perrigo Company plc
17.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.3.2. Product Portfolio
17.3.3.3. Financial Overview
17.3.3.4. SWOT Analysis
17.3.3.5. Strategic Overview
17.3.4. Pfizer, Inc.
17.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.4.2. Product Portfolio
17.3.4.3. Financial Overview
17.3.4.4. SWOT Analysis
17.3.4.5. Strategic Overview
17.3.5. Almirall, SA
17.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.5.2. Product Portfolio
17.3.5.3. Financial Overview
17.3.5.4. SWOT Analysis
17.3.5.5. Strategic Overview
17.3.6. Bausch Health Companies, Inc. (Valeant Pharmaceuticals International, Inc.)
17.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.6.2. Product Portfolio
17.3.6.3. Financial Overview
17.3.6.4. SWOT Analysis
17.3.6.5. Strategic Overview
17.3.7. Medimetriks Pharmaceuticals, Inc.
17.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.7.2. Product Portfolio
17.3.7.3. Financial Overview
17.3.7.4. SWOT Analysis
17.3.7.5. Strategic Overview
17.3.8. Taro Pharmaceutical Industries Ltd.
17.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.8.2. Product Portfolio
17.3.8.3. Financial Overview
17.3.8.4. SWOT Analysis
17.3.8.5. Strategic Overview
17.3.9. Mayne Pharma Group Ltd.
17.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.9.2. Product Portfolio
17.3.9.3. Financial Overview
17.3.9.4. SWOT Analysis
17.3.9.5. Strategic Overview

List of Tables

Table 01: Global Topical Antibiotics Market Size (US$ Mn) Forecast, by Drug Class, 2017–2031

Table 02: Global Topical Antibiotics Market Size (US$ Mn) Forecast, by Dosage Form, 2017–2031

Table 03: Global Topical Antibiotics Market Size (US$ Mn) Forecast, by Product Type, 2017–2031

Table 04: Global Topical Antibiotics Market Size (US$ Mn) Forecast, By Indication, 2017–2031

Table 05: Global Topical Antibiotics Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031

Table 06: Global Topical Antibiotics Market Size (US$ Mn) Forecast, by Region, 2017–2031

Table 07: North America Topical Antibiotics Market Size (US$ Mn) Forecast, by Country, 2017–2031

Table 08: North America Topical Antibiotics Market Size (US$ Mn) Forecast, by Drug Class, 2017–2031

Table 09: North America Topical Antibiotics Market Size (US$ Mn) Forecast, by Dosage Form, 2017–2031

Table 10: North America Topical Antibiotics Market Size (US$ Mn) Forecast, By Indication, 2017–2031

Table 11: North America Topical Antibiotics Market Size (US$ Mn) Forecast, by Product Type, 2017–2031

Table 12: North America Topical Antibiotics Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031

Table 13: Europe Topical Antibiotics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 14: Europe Topical Antibiotics Market Size (US$ Mn) Forecast, by Drug Class, 2017–2031

Table 15: Europe Topical Antibiotics Market Size (US$ Mn) Forecast, by Dosage Form, 2017–2031

Table 16: Europe Topical Antibiotics Market Size (US$ Mn) Forecast, By Indication, 2017–2031

Table 17: Europe Topical Antibiotics Market Size (US$ Mn) Forecast, by Product Type, 2017–2031

Table 18: Europe Topical Antibiotics Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031

Table 19: Asia Pacific Topical Antibiotics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 20: Asia Pacific Topical Antibiotics Market Size (US$ Mn) Forecast, by Drug Class, 2017–2031

Table 21: Asia Pacific Topical Antibiotics Market Size (US$ Mn) Forecast, by Dosage Form, 2017–2031

Table 22: Asia Pacific Topical Antibiotics Market Size (US$ Mn) Forecast, By Indication, 2017–2031

Table 23: Asia Pacific Topical Antibiotics Market Size (US$ Mn) Forecast, by Product Type, 2017–2031

Table 24: Asia Pacific Topical Antibiotics Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031

Table 25: Latin America Topical Antibiotics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 26: Latin America Topical Antibiotics Market Size (US$ Mn) Forecast, by Drug Class, 2017–2031

Table 27: Latin America Topical Antibiotics Market Size (US$ Mn) Forecast, by Dosage Form, 2017–2031

Table 28: Latin America Topical Antibiotics Market Size (US$ Mn) Forecast, By Indication, 2017–2031

Table 29: Latin America Topical Antibiotics Market Size (US$ Mn) Forecast, by Product Type, 2017–2031

Table 30: Latin America Topical Antibiotics Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031

Table 31: Middle East & Africa Topical Antibiotics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 32: Middle East & Africa Topical Antibiotics Market Size (US$ Mn) Forecast, by Drug Class, 2017–2031

Table 33: Middle East & Africa Topical Antibiotics Market Size (US$ Mn) Forecast, by Dosage Form, 2017–2031

Table 34: Middle East & Africa Topical Antibiotics Market Size (US$ Mn) Forecast, By Indication, 2017–2031

Table 35: Middle East & Africa Topical Antibiotics Market Size (US$ Mn) Forecast, by Product Type, 2017–2031

Table 36: Middle East & Africa Topical Antibiotics Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031

List of Figures

Figure 01: Global Topical Antibiotics Market Size (US$ Mn) and Distribution (%), by Region, 2022–2031

Figure 02: Global Topical Antibiotics Market Revenue (US$ Mn), by Drug Class, 2022

Figure 03: Global Topical Antibiotics Market Value Share, by Drug Class, 2022

Figure 04: Global Topical Antibiotics Market Revenue (US$ Mn), by Dosage Form, 2022

Figure 05: Global Topical Antibiotics Market Value Share, by Dosage Form, 2022

Figure 06: Global Topical Antibiotics Market Revenue (US$ Mn), By Indication, 2022

Figure 07: Global Topical Antibiotics Market Value Share, By Indication, 2022

Figure 08: Global Topical Antibiotics Market Revenue (US$ Mn), by Product Type, 2022

Figure 09: Global Topical Antibiotics Market Value Share, by Product Type, 2022

Figure 10: Global Topical Antibiotics Market Revenue (US$ Mn), by Distribution Channel, 2022

Figure 11: Global Topical Antibiotics Market Value Share, by Distribution Channel, 2022

Figure 12: Global Topical Antibiotics Market Value Share, by Region, 2022

Figure 13: Global Topical Antibiotics Market Value (US$ Mn) Forecast, 2017–2031

Figure 14: Global Topical Antibiotics Market Value Share Analysis, by Drug Class, 2022–2031

Figure 15: Global Topical Antibiotics Market Attractiveness Analysis, by Drug Class, 2023-2031

Figure 16: Global Topical Antibiotics Market Value Share Analysis, by Dosage Form, 2022–2031

Figure 17: Global Topical Antibiotics Market Attractiveness Analysis, by Dosage Form, 2023-2031

Figure 18: Global Topical Antibiotics Market Value Share Analysis, By Indication, 2022–2031

Figure 19: Global Topical Antibiotics Market Attractiveness Analysis, By Indication, 2023-2031

Figure 20: Global Topical Antibiotics Market Revenue (US$ Mn), by Product Type, 2022

Figure 21: Global Topical Antibiotics Market Value Share, by Product Type, 2022

Figure 22: Global Topical Antibiotics Market Revenue (US$ Mn), by Distribution Channel, 2022

Figure 23: Global Topical Antibiotics Market Value Share, by Distribution Channel, 2022

Figure 24: Global Topical Antibiotics Market Value Share Analysis, by Region, 2022–2031

Figure 25: Global Topical Antibiotics Market Attractiveness Analysis, by Region, 2023-2031

Figure 26: North America Topical Antibiotics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 27: North America Topical Antibiotics Market Attractiveness Analysis, by Country, 2023–2031

Figure 28: North America Topical Antibiotics Market Value Share Analysis, by Country, 2022–2031

Figure 29: North America Topical Antibiotics Market Value Share Analysis, by Drug Class, 2022–2031

Figure 30: North America Topical Antibiotics Market Value Share Analysis, by Dosage Form, 2022–2031

Figure 31: North America Topical Antibiotics Market Value Share Analysis, By Indication, 2022–2031

Figure 32: North America Topical Antibiotics Market Value Share Analysis, by Product Type, 2022–2031

Figure 33: North America Topical Antibiotics Market Value Share Analysis, by Distribution Channel, 2022–2031

Figure 34: North America Topical Antibiotics Market Attractiveness Analysis, by Drug Class, 2023–2031

Figure 35: North America Topical Antibiotics Market Attractiveness Analysis, by Dosage Form, 2023–2031

Figure 36: North America Topical Antibiotics Market Attractiveness Analysis, By Indication, 2023–2031

Figure 37: North America Topical Antibiotics Market Attractiveness Analysis, by Product Type, 2023–2031

Figure 38: North America Topical Antibiotics Market Attractiveness Analysis, by Distribution Channel, 2023–2031

Figure 39: Europe Topical Antibiotics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 40: Europe Topical Antibiotics Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 41: Europe Topical Antibiotics Market Value Share Analysis, by Country/Sub-region, 2022–2031

Figure 42: Europe Topical Antibiotics Market Value Share Analysis, by Drug Class, 2022–2031

Figure 43: Europe Topical Antibiotics Market Value Share Analysis, by Dosage Form, 2022–2031

Figure 44: Europe Topical Antibiotics Market Value Share Analysis, By Indication, 2022–2031

Figure 45: Europe Topical Antibiotics Market Value Share Analysis, by Product Type, 2022–2031

Figure 46: Europe Topical Antibiotics Market Value Share Analysis, by Distribution Channel, 2022–2031

Figure 47: Europe Topical Antibiotics Market Attractiveness Analysis, by Drug Class, 2023–2031

Figure 48: Europe Topical Antibiotics Market Attractiveness Analysis, by Dosage Form, 2023–2031

Figure 49: Europe Topical Antibiotics Market Attractiveness Analysis, By Indication, 2023–2031

Figure 50: Europe Topical Antibiotics Market Attractiveness Analysis, by Product Type, 2023–2031

Figure 51: Europe Topical Antibiotics Market Attractiveness Analysis, by Distribution Channel, 2023–2031

Figure 52: Asia Pacific Topical Antibiotics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 53: Asia Pacific Topical Antibiotics Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 54: Asia Pacific Topical Antibiotics Market Value Share Analysis, by Country/Sub-region, 2022–2031

Figure 55: Asia Pacific Topical Antibiotics Market Value Share Analysis, by Drug Class, 2022–2031

Figure 56: Asia Pacific Topical Antibiotics Market Value Share Analysis, by Dosage Form, 2022–2031

Figure 57: Asia Pacific Topical Antibiotics Market Value Share Analysis, By Indication, 2022–2031

Figure 58: Asia Pacific Topical Antibiotics Market Value Share Analysis, by Product Type, 2022–2031

Figure 59: Asia Pacific Topical Antibiotics Market Value Share Analysis, by Distribution Channel, 2022–2031

Figure 60: Asia Pacific Topical Antibiotics Market Attractiveness Analysis, by Drug Class, 2023–2031

Figure 61: Asia Pacific Topical Antibiotics Market Attractiveness Analysis, by Dosage Form, 2023–2031

Figure 62: Asia Pacific Topical Antibiotics Market Attractiveness Analysis, By Indication, 2023–2031

Figure 63: Asia Pacific Topical Antibiotics Market Attractiveness Analysis, by Product Type, 2023–2031

Figure 64: Asia Pacific Topical Antibiotics Market Attractiveness Analysis, by Distribution Channel, 2023–2031

Figure 65: Latin America Topical Antibiotics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 66: Latin America Topical Antibiotics Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 67: Latin America Topical Antibiotics Market Value Share Analysis, by Country/Sub-region, 2022–2031

Figure 68: Latin America Topical Antibiotics Market Value Share Analysis, by Drug Class, 2022–2031

Figure 69: Latin America Topical Antibiotics Market Value Share Analysis, by Dosage Form, 2022–2031

Figure 70: Latin America Topical Antibiotics Market Value Share Analysis, By Indication, 2022–2031

Figure 71: Latin America Topical Antibiotics Market Value Share Analysis, by Product Type, 2022–2031

Figure 72: Latin America Topical Antibiotics Market Value Share Analysis, by Distribution Channel, 2022–2031

Figure 73: Latin America Topical Antibiotics Market Attractiveness Analysis, by Drug Class, 2023–2031

Figure 74: Latin America Topical Antibiotics Market Attractiveness Analysis, by Dosage Form, 2023–2031

Figure 75: Latin America Topical Antibiotics Market Attractiveness Analysis, By Indication, 2023–2031

Figure 76: Latin America Topical Antibiotics Market Attractiveness Analysis, by Product Type, 2023–2031

Figure 77: Latin America Topical Antibiotics Market Attractiveness Analysis, by Distribution Channel, 2023–2031

Figure 78: Middle East & Africa Topical Antibiotics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 79: Middle East & Africa Topical Antibiotics Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 80: Middle East & Africa Topical Antibiotics Market Value Share Analysis, by Country/Sub-region, 2022–2031

Figure 81: Middle East & Africa Topical Antibiotics Market Value Share Analysis, by Drug Class, 2022–2031

Figure 82: Middle East & Africa Topical Antibiotics Market Value Share Analysis, by Dosage Form, 2022–2031

Figure 83: Middle East & Africa Topical Antibiotics Market Value Share Analysis, By Indication, 2022–2031

Figure 84: Middle East & Africa Topical Antibiotics Market Value Share Analysis, by Product Type, 2022–2031

Figure 85: Middle East & Africa Topical Antibiotics Market Value Share Analysis, by Distribution Channel, 2022–2031

Figure 86: Middle East & Africa Topical Antibiotics Market Attractiveness Analysis, by Drug Class, 2023–2031

Figure 87: Middle East & Africa Topical Antibiotics Market Attractiveness Analysis, by Dosage Form, 2023–2031

Figure 88: Middle East & Africa Topical Antibiotics Market Attractiveness Analysis, By Indication, 2023–2031

Figure 89: Middle East & Africa Topical Antibiotics Market Attractiveness Analysis, by Product Type, 2023–2031

Figure 90: Middle East & Africa Topical Antibiotics Market Attractiveness Analysis, by Distribution Channel, 2023–2031

△ 一番上に戻る